TX
|
75-2533518
|
|
(State
or other jurisdiction
|
(I.R.S.
Employer
|
|
of
incorporation or organization)
|
Identification
No.)
|
Suite
210, LB-59, Dallas, TX
|
75206
|
|
(Zip
Code)
|
Page
Number
|
||
PART
I. FINANCIAL INFORMATION
|
||
Item
1. Financial
Statements (Unaudited)
|
3
|
|
Statements
of Assets and Liabilities as of March 31, 2007 and December 31,
2006
|
3
|
|
Schedules
of Investments as of March 31, 2007 and December 31, 2006
|
4
|
|
|
||
Statements
of Operations for the three months ended March 31, 2007 and
2006
|
14
|
|
Statements
of Changes in Net Assets for the three months ended March 31, 2007
and
2006
|
15
|
|
Statements
of Cash Flows for the three months ended March 31, 2007 and
2006
|
16
|
|
Notes
to Financial Statements
|
17
|
|
Item
2. Management’s
Discussion and Analysis of Financial Condition and Results of
Operations
|
23
|
|
Item
3. Quantitative and Qualitative Disclosures About Market
Risk
|
25
|
|
Item
4. Controls and Procedures
|
25
|
|
PART
II. OTHER INFORMATION
|
||
Item
1. Legal
Proceedings
|
26
|
|
Item
1A. Risk
Factors
|
26
|
|
Item
2. Unregistered
Sales of Equity Securities and Use of
Proceeds
|
28
|
|
Item
3. Defaults
Upon Senior Securities
|
28
|
|
Item
4. Submission
of Matters to a Vote of Security Holders
|
28
|
|
Item
5. Other
Information
|
28
|
|
Item
6. Exhibits
|
28
|
March
31, 2007
|
December
31, 2006
|
||||||
ASSETS
|
|||||||
Cash
and cash equivalents
|
$
|
4,199,497
|
$
|
14,835,500
|
|||
Investments
at fair value, cost of $39,066,672
|
|||||||
and
$38,413,046 at March 31, 2007 and
|
|||||||
December
31, 2006, respectively
|
44,768,387
|
43,642,143
|
|||||
Interest
and dividend receivables
|
79,452
|
146,146
|
|||||
Prepaid
and other assets
|
9,479
|
25,766
|
|||||
$
|
49,056,815
|
$
|
58,649,555
|
||||
LIABILITIES
AND NET ASSETS
|
|||||||
Liabilities:
|
|||||||
Accounts
payable
|
$
|
119,081
|
$
|
168,845
|
|||
Accounts
payable - affiliate
|
212,676
|
3,810,462
|
|||||
Taxes
payable on behalf of stockholders
|
-
|
6,302,806
|
|||||
331,757
|
10,282,113
|
||||||
Commitments
and contingencies
|
|||||||
Net
assets:
|
|||||||
Common
stock, $1 par value; authorized 20,000,000
|
|||||||
shares;
4,673,867 shares issued; 4,463,967 shares
|
|||||||
outstanding
|
4,673,867
|
4,673,867
|
|||||
Additional
paid-in-capital
|
28,379,231
|
28,494,233
|
|||||
Treasury
stock at cost, 209,900 shares
|
(1,734,967
|
)
|
(1,734,967
|
)
|
|||
Net
realized gain on investments retained
|
11,705,212
|
11,705,212
|
|||||
Net
unrealized appreciation of investments
|
5,701,715
|
5,229,097
|
|||||
Net
assets, equivalent to $10.92 and $10.84 per share
|
|||||||
at
March 31, 2007 and December 31, 2006,
|
|||||||
48,725,058
|
48,367,442
|
||||||
$
|
49,056,815
|
$
|
58,649,555
|
|
|
March
31, 2007
|
|
|||||||||||||
|
|
Interest
|
|
Due
|
|
|
|
Fair
|
|
%
of Net
|
|
|||||
|
|
Rate
|
|
Date
|
|
Cost
|
|
Value
|
|
Investments
|
|
|||||
Eligible
Portfolio Investments -
|
||||||||||||||||
Convertible
Debentures and
|
||||||||||||||||
Promissory
Notes
|
||||||||||||||||
CaminoSoft
Corp. -
|
||||||||||||||||
Promissory
note (4)
|
7.00
|
%
|
01/19/08
|
$
|
250,000
|
$
|
250,000
|
0.56
|
%
|
|||||||
iLinc
Communications, Inc. -
|
||||||||||||||||
Convertible
promissory note
|
12.00
|
03/29/12
|
500,000
|
500,000
|
1.12
|
|||||||||||
Integrated
Security Systems, Inc. -
|
||||||||||||||||
Promissory
note (4)
|
8.00
|
09/30/07
|
525,000
|
525,000
|
1.17
|
|||||||||||
Promissory
note (4)
|
7.00
|
09/30/07
|
200,000
|
200,000
|
0.45
|
|||||||||||
Promissory
note (4)
|
8.00
|
09/30/07
|
175,000
|
175,000
|
0.39
|
|||||||||||
Convertible
promissory note (2)
|
8.00
|
12/14/08
|
500,000
|
500,000
|
1.12
|
|||||||||||
Convertible
debenture (4)
|
6.00
|
06/16/09
|
400,000
|
400,000
|
0.89
|
|||||||||||
Pipeline
Data, Inc. -
|
||||||||||||||||
Convertible
debenture (2)
|
8.00
|
06/29/10
|
500,000
|
500,000
|
1.12
|
|||||||||||
Simtek
Corporation -
|
||||||||||||||||
Convertible
debenture
|
7.50
|
06/28/09
|
900,000
|
2,327,728
|
5.20
|
|||||||||||
$
|
3,950,000
|
$
|
5,377,728
|
12.02
|
%
|
March
31, 2007
|
|
||||||||||||
|
|
|
|
|
|
Fair
|
|
%
of Net
|
|
||||
|
|
Shares
|
|
Cost
|
|
Value
|
|
Investments
|
|||||
Eligible
Portfolio Investments -
|
|||||||||||||
Common
Stock, Preferred Stock,
|
|||||||||||||
and
Miscellaneous Securities
|
|||||||||||||
Advance
Nanotech, Inc. -
|
|||||||||||||
Common
stock
|
165,000
|
$
|
330,000
|
$
|
79,200
|
0.17
|
%
|
||||||
Common
stock (2)
|
5,796
|
0
|
2,782
|
0.01
|
|
||||||||
CaminoSoft
Corp. -
|
|||||||||||||
Common
stock
|
3,539,414
|
5,275,000
|
743,277
|
1.66
|
|||||||||
Digital
Learning Management Corporation -
|
|||||||||||||
Common
stock (2)
|
166,666
|
12,500
|
9,667
|
0.02
|
|||||||||
eOriginal,
Inc. -
|
|||||||||||||
Series
A, preferred stock (1)(3)
|
10,680
|
4,692,207
|
332,575
|
0.74
|
|||||||||
Series
B, preferred stock (1)(3)
|
25,646
|
620,329
|
798,616
|
1.79
|
|||||||||
Series
C, preferred stock (1)(3)
|
51,249
|
1,059,734
|
1,595,894
|
3.56
|
|||||||||
Series
D, preferred stock (1)(3)
|
16,057
|
500,000
|
500,015
|
1.12
|
|||||||||
Gaming
& Entertainment Group -
|
|||||||||||||
Common
stock
|
612,500
|
550,625
|
12,250
|
0.03
|
|||||||||
Gasco
Energy, Inc. -
|
|||||||||||||
Common
stock
|
1,541,666
|
1,250,000
|
3,761,665
|
8.40
|
|||||||||
Global
Axcess Corporation -
|
|||||||||||||
Common
stock
|
953,333
|
1,261,667
|
314,600
|
0.70
|
|||||||||
Hemobiotech,
Inc. -
|
|||||||||||||
Common
stock
|
1,137,405
|
1,143,882
|
2,274,810
|
5.08
|
|||||||||
i2
Telecom -
|
|||||||||||||
Convertible
Preferred (2)
|
625
|
618,750
|
453,125
|
1.01
|
|||||||||
Common
stock (2)
|
237,510
|
36,200
|
34,439
|
0.08
|
|||||||||
Integrated
Security Systems, Inc. -
|
|||||||||||||
Common
stock (2)
|
31,939,794
|
5,990,572
|
3,832,775
|
8.56
|
|||||||||
Series
D, preferred stock (2)
|
187,500
|
150,000
|
22,500
|
0.05
|
|
|
March
31, 2007
|
|
||||||||||
|
|
|
|
|
|
Fair
|
|
%
of Net
|
|
||||
|
|
Shares
|
|
Cost
|
|
Value
|
|
Investments
|
|||||
Eligible
Portfolio Investments -
|
|||||||||||||
Common
Stock, Preferred Stock,
|
|||||||||||||
and
Miscellaneous Securities, continued
|
|||||||||||||
Inyx,
Inc. -
|
|||||||||||||
Common
stock
|
300,000
|
300,000
|
765,000
|
1.71
|
|||||||||
PracticeXpert,
Inc. -
|
|||||||||||||
Common
stock
|
4,166,667
|
500,000
|
8,333
|
0.02
|
|||||||||
Shea
Development Corp.
|
|||||||||||||
(formerly
Information Intellect) -
|
|||||||||||||
Common
stock (1)(3)
|
1,437,194
|
1,093,332
|
1,180,731
|
2.64
|
|||||||||
Simtek
Corp. -
|
|||||||||||||
Common
stock
|
639,603
|
1,795,000
|
3,639,339
|
8.13
|
|||||||||
Common
stock (2)
|
1,160
|
4,294
|
6,600
|
0.01
|
|||||||||
Symbollon
Pharmaceuticals, Inc. -
|
|||||||||||||
Common
stock (2)
|
250,000
|
250,000
|
237,500
|
0.53
|
|||||||||
Miscellaneous
Securities
|
-
|
476,257
|
1.06
|
||||||||||
$
|
27,434,092
|
$
|
21,081,950
|
47.08
|
%
|
March
31, 2007
|
|
||||||||||||
|
|
|
|
|
|
Fair
|
|
%
of Net
|
|
||||
|
|
Shares
|
|
Cost
|
|
Value
|
|
Investments
|
|||||
Other
Portfolio Investments -
|
|||||||||||||
Common
Stock, Preferred Stock,
|
|||||||||||||
and
Miscellaneous Securities
|
|||||||||||||
Access
Plans USA, Inc. -
|
|||||||||||||
Common
stock
|
890,500
|
$
|
2,139,777
|
$
|
2,092,675
|
4.68
|
%
|
||||||
AdStar,
Inc. (formerly Precis) -
|
|||||||||||||
Common
stock
|
269,231
|
350,000
|
640,770
|
1.43
|
|||||||||
Asian
Financial, Inc. -
|
|||||||||||||
Common
stock (1)(3)
|
349,205
|
500,000
|
500,000
|
1.12
|
|||||||||
Bovie
Medical Corporation -
|
|||||||||||||
Common
stock
|
500,000
|
907,845
|
3,550,000
|
7.93
|
|||||||||
China
Security & Surveillance Technology, Inc. -
|
|||||||||||||
Common
stock (2)
|
142,857
|
500,000
|
2,335,712
|
5.22
|
|||||||||
Comtech
Group, Inc. -
|
|||||||||||||
Common
stock
|
300,000
|
1,186,019
|
5,244,000
|
11.71
|
|||||||||
Hemobiotech,
Inc. -
|
|||||||||||||
Common
stock
|
62,595
|
140,235
|
125,190
|
0.28
|
|||||||||
iLinc
Communications, Inc. -
|
|||||||||||||
Common
stock
|
23,266
|
13,908
|
15,356
|
0.03
|
|||||||||
Common
stock
|
30,150
|
237,209
|
720,585
|
1.61
|
March
31, 2007
|
|
||||||||||||
|
|
|
|
|
|
Fair
|
|
%
of Net
|
|
||||
|
|
Shares
|
|
Cost
|
|
Value
|
|
Investments
|
|||||
Other
Portfolio Investments -
|
|||||||||||||
Common
Stock, Preferred Stock,
|
|||||||||||||
and
Miscellaneous Securities, continued
|
|||||||||||||
Points
International, Ltd. -
|
|||||||||||||
Common
stock
|
900,000
|
492,000
|
837,000
|
1.87
|
|
||||||||
Silverleaf
Resorts, Inc. -
|
|||||||||||||
Common
stock
|
100,000
|
430,000
|
465,000
|
1.04
|
|||||||||
US
Home Systems, Inc. -
|
|||||||||||||
Common
stock
|
110,000
|
535,587
|
1,402,500
|
3.13
|
|||||||||
Vaso
Active Pharmaceuticals, Inc. -
|
|||||||||||||
Common
stock
|
150,000
|
250,000
|
49,500
|
0.11
|
|||||||||
Miscellaneous
Securities
|
-
|
330,421
|
0.74
|
||||||||||
7,682,580
|
18,308,709
|
40.90
|
%
|
||||||||||
$
|
39,066,672
|
$
|
44,768,387
|
100.00
|
%
|
||||||||
Allocation
of Investments -
|
|||||||||||||
Restricted
Shares, Unrestricted Shares,
|
|||||||||||||
and
Other Securities
|
|||||||||||||
Restricted
Securities (2)
|
$
|
8,562,316
|
$
|
7,935,100
|
17.73
|
%
|
|||||||
Unrestricted
Securities
|
$
|
20,488,754
|
$
|
29,568,778
|
66.04
|
%
|
|||||||
Other
Securities (5)
|
$
|
10,015,602
|
$
|
7,264,509
|
16.23
|
%
|
(1) |
Valued
at fair value as determined by the Investment Adviser (Note
6).
|
(2) |
Restricted
securities - securities that are not freely tradable (there is not
a valid
registration statement on file or an
available exemption from
registration.)
|
(3) |
Securities
in a privately owned company, which by nature are restricted securities
(not freely tradable).
|
(4) |
Securities
that have no provision allowing conversion into a security for which
there
is a public market.
|
(5) |
Includes
Miscellaneous Securities, securities of privately owned companies,
and
securities with no conversion feature.
|
December
31, 2006
|
|
|||||||||||||||
|
|
Interest
|
|
Due
|
|
|
|
Fair
|
|
%
of Net
|
|
|||||
|
|
Rate
|
|
Date
|
|
Cost
|
|
Value
|
|
Investments
|
||||||
Eligible
Portfolio Investments -
|
||||||||||||||||
Convertible
Debentures and
|
||||||||||||||||
Promissory
Notes
|
||||||||||||||||
CaminoSoft
Corp. -
|
||||||||||||||||
Promissory
note (4)
|
7.00
|
%
|
01/19/08
|
$
|
250,000
|
$
|
250,000
|
0.57
|
%
|
|||||||
iLinc
Communications, Inc. -
|
||||||||||||||||
Convertible
promissory note
|
12.00
|
03/29/12
|
500,000
|
500,000
|
1.15
|
|||||||||||
Integrated
Security Systems, Inc. -
|
||||||||||||||||
Promissory
note (4)
|
8.00
|
09/30/07
|
525,000
|
525,000
|
1.20
|
|||||||||||
Promissory
note (4)
|
7.00
|
09/30/07
|
200,000
|
200,000
|
0.46
|
|||||||||||
Promissory
note (4)
|
8.00
|
09/30/07
|
175,000
|
175,000
|
0.40
|
|||||||||||
Convertible
promissory note (2)
|
8.00
|
12/14/08
|
500,000
|
500,000
|
1.15
|
|||||||||||
Convertible
debenture (4)
|
6.00
|
06/16/09
|
400,000
|
400,000
|
0.91
|
|||||||||||
Pipeline
Data, Inc. -
|
||||||||||||||||
Convertible
debenture (2)
|
8.00
|
06/29/10
|
500,000
|
500,000
|
1.15
|
|||||||||||
Simtek
Corporation -
|
||||||||||||||||
Convertible
debenture
|
7.50
|
06/28/09
|
900,000
|
1,902,273
|
4.36
|
|||||||||||
$
|
3,950,000
|
$
|
4,952,273
|
11.35
|
%
|
|
|
December
31, 2006
|
|
||||||||||
|
|
|
|
|
|
Fair
|
|
%
of Net
|
|
||||
|
|
Shares
|
|
Cost
|
|
Value
|
|
Investments
|
|||||
Eligible
Portfolio Investments -
|
|||||||||||||
Common
Stock, Preferred Stock,
|
|||||||||||||
and
Miscellaneous Securities
|
|||||||||||||
Advance
Nanotech, Inc. -
|
|||||||||||||
Common
stock (2)
|
170,796
|
$
|
330,000
|
$
|
121,265
|
0.28
|
%
|
||||||
CaminoSoft
Corp. -
|
|||||||||||||
Common
stock
|
3,539,414
|
5,275,000
|
1,592,736
|
3.65
|
|||||||||
Digital
Learning Management Corporation -
|
|||||||||||||
Common
stock (2)
|
166,666
|
12,500
|
13,333
|
0.03
|
|||||||||
eOriginal,
Inc. -
|
|||||||||||||
Series
A, preferred stock (1)(3)
|
10,680
|
4,692,207
|
332,575
|
0.76
|
|||||||||
Series
B, preferred stock (1)(3)
|
25,646
|
620,329
|
798,616
|
1.83
|
|||||||||
Series
C, preferred stock (1)(3)
|
51,249
|
1,059,734
|
1,595,894
|
3.66
|
|||||||||
Series
D, preferred stock (1)(3)
|
16,057
|
500,000
|
500,015
|
1.15
|
|||||||||
Gaming
& Entertainment Group, Inc. -
|
|||||||||||||
Common
stock
|
500,000
|
500,000
|
12,500
|
0.03
|
|||||||||
Common
stock (2)
|
112,500
|
50,625
|
2,813
|
0.01
|
|||||||||
Gasco
Energy, Inc. -
|
|||||||||||||
Common
stock
|
1,541,666
|
1,250,000
|
3,777,082
|
8.65
|
|||||||||
Global
Axcess Corporation -
|
|||||||||||||
Common
stock
|
953,333
|
1,261,667
|
352,733
|
0.81
|
|||||||||
Hemobiotech,
Inc. -
|
|||||||||||||
Common
stock
|
1,137,405
|
1,143,882
|
2,331,680
|
5.34
|
|||||||||
i2
Telecom -
|
|||||||||||||
Convertible
Preferred (2)
|
625
|
618,750
|
85,938
|
0.20
|
|||||||||
Common
stock (2)
|
237,510
|
36,200
|
26,126
|
0.06
|
|||||||||
Common
stock (1)(3)
|
666,666
|
999,999
|
999,999
|
2.29
|
December
31, 2006
|
|
||||||||||||
|
|
|
|
|
|
Fair
|
|
%
of Net
|
|
||||
|
|
Shares
|
|
Cost
|
|
Value
|
|
Investments
|
|||||
Eligible
Portfolio Investments -
|
|||||||||||||
Common
Stock, Preferred Stock,
|
|||||||||||||
and
Miscellaneous Securities, continued
|
|||||||||||||
Integrated
Security Systems, Inc. -
|
|||||||||||||
Common
stock
|
27,074,179
|
5,568,054
|
3,790,385
|
8.70
|
|||||||||
Common
stock (2)
|
4,264,854
|
356,225
|
597,080
|
1.36
|
|||||||||
Series
D, preferred stock (2)
|
187,500
|
150,000
|
26,250
|
0.06
|
|||||||||
Inyx,
Inc. -
|
|||||||||||||
Common
stock
|
300,000
|
300,000
|
699,000
|
1.60
|
|||||||||
PracticeXpert,
Inc. -
|
|||||||||||||
Common
stock
|
4,166,667
|
500,000
|
12,500
|
0.03
|
|||||||||
Simtek
Corp. -
|
|||||||||||||
Common
stock
|
639,603
|
1,795,000
|
2,974,153
|
6.81
|
|||||||||
Common
stock (2)
|
1,160
|
4,294
|
5,392
|
0.01
|
|||||||||
Symbollon
Pharmaceuticals, Inc. -
|
|||||||||||||
Common
stock (2)
|
250,000
|
250,000
|
225,000
|
0.51
|
|||||||||
Miscellaneous
Securities
|
-
|
407,822
|
0.93
|
||||||||||
$
|
27,274,466
|
$
|
21,280,887
|
48.76
|
%
|
December
31, 2006
|
|
||||||||||||
|
|
|
|
|
|
Fair
|
|
%
of Net
|
|
||||
|
|
Shares
|
|
Cost
|
|
Value
|
|
Investments
|
|||||
Other
Portfolio Investments -
|
|||||||||||||
Common
Stock, Preferred Stock,
|
|||||||||||||
and
Miscellaneous Securities
|
|||||||||||||
AdStar,
Inc. -
|
|||||||||||||
Common
stock
|
269,231
|
$
|
350,000
|
$
|
619,231
|
1.42
|
%
|
||||||
Asian
Financial, Inc. -
|
|||||||||||||
Common
stock (1)(3)
|
130,208
|
500,000
|
500,000
|
1.15
|
|||||||||
Bovie
Medical Corporation -
|
|||||||||||||
Common
stock
|
500,000
|
907,845
|
4,535,000
|
10.39
|
|||||||||
China
Security & Surveillance Technology, Inc. -
|
|||||||||||||
Common
stock (2)
|
142,857
|
500,000
|
1,728,570
|
3.96
|
|||||||||
Comtech
Group, Inc. -
|
|||||||||||||
Common
stock
|
300,000
|
1,186,019
|
5,457,000
|
12.51
|
|||||||||
Hemobiotech,
Inc. -
|
|||||||||||||
Common
stock
|
62,595
|
140,235
|
128,320
|
0.29
|
|||||||||
iLinc
Communications, Inc. -
|
|||||||||||||
Common
stock
|
23,266
|
13,908
|
13,727
|
0.03
|
|||||||||
Medical
Action Industries, Inc. -
|
|||||||||||||
Common
stock
|
20,100
|
237,209
|
648,024
|
1.49
|
December
31, 2006
|
|
||||||||||||
|
|
|
|
|
Fair
|
|
%
of Net
|
|
|||||
|
|
Shares
|
|
Cost
|
|
Value
|
|
Investments
|
|||||
Other
Portfolio Investments -
|
|||||||||||||
Common
Stock, Preferred Stock,
|
|||||||||||||
and
Miscellaneous Securities, continued
|
|||||||||||||
Points
International, Ltd. -
|
|||||||||||||
Common
stock
|
800,000
|
428,000
|
512,000
|
1.17
|
|||||||||
Precis,
Inc. -
|
|||||||||||||
Common
stock
|
890,500
|
2,139,777
|
1,786,343
|
4.09
|
|||||||||
US
Home Systems, Inc. -
|
|||||||||||||
Common
stock
|
110,000
|
535,587
|
1,245,200
|
2.85
|
|||||||||
Vaso
Active Pharmaceuticals, Inc. -
|
|||||||||||||
Common
stock
|
150,000
|
250,000
|
27,000
|
0.06
|
|||||||||
Miscellaneous
Securities
|
-
|
208,568
|
0.48
|
||||||||||
7,188,580
|
17,408,983
|
39.89
|
%
|
||||||||||
$
|
38,413,046
|
$
|
43,642,143
|
100.00
|
%
|
||||||||
Allocation
of Investments -
|
|||||||||||||
Restricted
Shares, Unrestricted Shares,
|
|||||||||||||
and
Other Securities
|
|||||||||||||
Restricted
Securities (2)
|
$
|
3,308,594
|
$
|
3,831,767
|
8.78
|
%
|
|||||||
Unrestricted
Securities
|
$
|
25,182,183
|
$
|
32,916,887
|
75.42
|
%
|
|||||||
Other
Securities (5)
|
$
|
9,922,269
|
$
|
6,893,489
|
15.80
|
%
|
(1) |
Valued
at fair value as determined by the Investment Adviser (Note
6).
|
(2) |
Restricted
securities - securities that are not freely tradable (there is not
a valid
registration statement on file or an available exemption from
registration.)
|
(3) |
Securities
in a privately owned company, which by nature are restricted securities
(not freely tradable).
|
(4) |
Securities
that have no provision allowing conversion into a security for which
there
is a public market.
|
(5) |
Includes
Miscellaneous Securities, securities of privately owned companies
and
securities with no conversion feature.
|
Three
Months Ended March 31,
|
|
||||||
|
|
2007
|
|
2006
|
|||
Income:
|
|||||||
Interest
income
|
$
|
79,304
|
$
|
65,055
|
|||
Dividend
income
|
208,884
|
42,465
|
|||||
Other
income
|
10,876
|
15,109
|
|||||
299,064
|
122,629
|
||||||
Expenses:
|
|||||||
General
and administrative
|
87,156
|
61,223
|
|||||
Interest
expense
|
-
|
27,810
|
|||||
Legal
and professional fees
|
112,802
|
168,023
|
|||||
Management
fee to affiliate
|
214,109
|
238,747
|
|||||
414,067
|
495,803
|
||||||
Net
investment loss
|
(115,003
|
)
|
(373,174
|
)
|
|||
Realized
and unrealized gain (loss)
|
|||||||
on
investments:
|
|||||||
Net
change in unrealized appreciation
|
|||||||
of
investments
|
472,619
|
(225,650
|
)
|
||||
Net
realized gain on investments
|
-
|
1,188,192
|
|||||
Net
gain on investments
|
472,619
|
962,542
|
|||||
Net
income
|
$
|
357,616
|
$
|
589,368
|
|||
Net
income per share
|
$
|
0.08
|
$
|
0.13
|
|||
Weighted
average shares outstanding
|
4,463,967
|
4,463,967
|
Three
Months Ended March 31,
|
|
||||||
|
|
2007
|
|
2006
|
|||
From
operations:
|
|||||||
Net
investment loss
|
$
|
(115,003
|
)
|
$
|
(373,174
|
)
|
|
Net
realized gain on investments
|
-
|
1,188,192
|
|||||
Net
change in unrealized
|
|||||||
appreciation
on investments
|
472,619
|
(225,650
|
)
|
||||
Net
income
|
357,616
|
589,368
|
|||||
From
distributions to stockholders:
|
|||||||
Common
stock dividends declared from realized
|
|||||||
capital
gains
|
-
|
(446,397
|
)
|
||||
Total
increase in net assets
|
357,616
|
142,971
|
|||||
Net
assets:
|
|||||||
Beginning
of period
|
48,367,442
|
54,188,943
|
|||||
End
of period
|
$
|
48,725,058
|
$
|
54,331,914
|
Three
Months Ended March 31,
|
|
||||||
|
|
2007
|
|
2006
|
|||
Cash
flows from operating activities:
|
|||||||
Net
income
|
$
|
357,616
|
$
|
589,368
|
|||
Adjustments
to reconcile net income to net cash
|
|||||||
provided
by (used in) operation activities:
|
|||||||
Net
change in unrealized appreciation
|
|||||||
on
investments
|
(472,619
|
)
|
225,650
|
||||
Net
realized (gain) on investments
|
-
|
(1,188,192
|
)
|
||||
(Increase)
decrease in interest and
|
|||||||
dividend
receivables
|
66,694
|
(117,646
|
)
|
||||
Decrease
in prepaid
|
|||||||
and
other assets
|
16,287
|
74,850
|
|||||
Increase
(decrease) in accounts payable
|
(49,765
|
)
|
37,664
|
||||
Increase
(decrease) in accounts payable-affiliate
|
(3,597,786
|
)
|
237,717
|
||||
Decrease
in taxes payable on behalf of shareholders
|
(6,302,806
|
)
|
-
|
||||
Increase
in due to broker
|
-
|
50,022
|
|||||
Purchase
of investments
|
(653,624
|
)
|
(676,746
|
)
|
|||
Proceeds
from sale of investments
|
-
|
1,364,592
|
|||||
Net
cash provided by (used in) operating activities
|
(10,636,003
|
)
|
597,279
|
||||
Cash
flows from financing activities:
|
|||||||
Cash
dividends
|
-
|
(4,592,083
|
)
|
||||
Net
(decrease) in cash
|
|||||||
and
cash equivalents
|
(10,636,003
|
)
|
(3,994,804
|
)
|
|||
Cash
and cash equivalents at
|
|||||||
beginning
of the period
|
14,835,500
|
8,396,052
|
|||||
Cash
and cash equivalents at
|
|||||||
end
of the period
|
$
|
4,199,497
|
$
|
4,401,248
|
|||
Cash
paid during the period for interest
|
$
|
-
|
$
|
27,810
|
·
|
The
Investment Adviser receives a management fee equal to a quarterly
rate of
0.4375% of the Fund’s net assets, as determined at the end of such quarter
with each such payment to be due as of the last day of the calendar
quarter. The Fund incurred $214,109
and $238,747 for management fees during the quarter ended March
31, 2007
and 2006, respectively.
|
·
|
The Investment Adviser receives
an
incentive fee in an amount equal to 20% of the Fund’s cumulative realized
capital gains in excess of cumulative realized capital losses of
the Fund
after allowance for any unrealized capital depreciation on the portfolio
investments of the Fund at the end of the period being calculated
less
cumulative incentive fees previously accrued. Unrealized capital
depreciation equals net unrealized capital losses on each class of
security without netting net unrealized capital gains on other classes
of
securities. The incentive fee is calculated, accrued, and paid on
an
annual basis as of year end. Because the incentive fee is calculated,
accrued, and paid on an annual basis as of each year end and no
probability or estimate of the ultimate fee can be ascertained (see
note
9), no incentive fee was recorded during the quarter ended March
31, 2007
and March
31, 2006.
|
·
|
The Investment Adviser was reimbursed
by
the Fund for directly allocable administrative expenses paid by the
Investment Adviser on behalf of the Fund. Such reimbursements were
$106,382 and $7,236 during the quarter ended March
31, 2007
and 2006, respectively.
|
·
|
The
common stock of companies listed on an exchange, Nasdaq or in the
over-the-counter market is valued at the closing price on the date
of
valuation.
|
·
|
The
unlisted preferred stock of companies with common stock listed on
an
exchange, Nasdaq or in the over-the-counter market is valued at the
closing price of the common stock into which the preferred stock
is
convertible on the date of valuation. If the preferred stock is
redeemable, the preferred stock is valued at the greater of cost
or
market.
|
·
|
The
unlisted in-the-money options or warrants of companies with the underlying
common stock listed on an exchange, Nasdaq or in the over-the-counter
market are valued at the positive difference between the closing
price of
the underlying common stock and the strike price of the warrant or
option.
An out-of-the money warrant or option has no intrinsic value; thus,
we
assign no value to it.
|
·
|
Debt
securities are valued at the greater of (i) cost or (ii) the market
value
of the underlying common stock into which the debt instrument is
convertible. In cases where the debt instrument is in default or
the
company is in bankruptcy, the value will be (i) the value of the
underlying common stock, (ii) the value of the collateral, if secured,
or
(iii) zero, if the common stock has no value and there is no
collateral.
|
·
|
If
there is no independent and objective pricing authority (i.e. a public
market) for investments in privately held entities, the latest sale
of
equity securities to independent third parties by the entity governs
the
value of that enterprise. This valuation method causes the Fund’s initial
investment in the private entity to be valued at cost. Thereafter,
new
issuances or offers of equity or equity-linked securities by the
portfolio
company to new investors will be used to determine enterprise value
as
they will provide the most objective and independent basis for determining
the worth of the issuer. Where a private entity does not have an
independent value established over an extended period of time, then
the
Investment Adviser will determine fair value on the basis of appraisal
procedures established in good faith and approved by the Fund’s Board of
Directors.
|
2007
|
|
2006
|
|||||
Net
asset value, beginning of period
|
$
|
10.84
|
$
|
12.14
|
|||
Net
investment loss
|
(0.03
|
)
|
(0.08
|
)
|
|||
Net
realized and unrealized gain on investments
|
0.11
|
0.21
|
|||||
Total
return from investment operations
|
0.08
|
0.13
|
|||||
Distributions:
|
|||||||
From
net capital gains
|
0.00
|
(0.10
|
)
|
||||
Net
asset value, end of period
|
$
|
10.92
|
$
|
12.17
|
|||
Per
share market value, end of period
|
$
|
9.15
|
$
|
10.90
|
|||
Portfolio
turnover rate
|
0.00
|
%
|
1.25
|
%
|
|||
Quarterly
return (a)
|
(12.86
|
)%
|
(0.91
|
)%
|
|||
Ratio
to average net assets (b):
|
|||||||
Net
investment loss
|
(0.24
|
)%
|
(0.69
|
)%
|
|||
0.41
|
%
|
0.91
|
%
|
(a) |
Quarterly
return (not annualized) was calculated by comparing the common stock
price
on the first day of the period to the common stock price on the last
day
of the period, in accordance with American Institute of Certified
Public
Account guidelines.
|
(b) | Average net assets have been computed based on quarterly valuations. |
/s/ Russell Cleveland | May 15, 2007 | ||
|
|||
Russell
Cleveland, President and
Chief
Executive Officer
(Principal
Executive Officer)
|
/s/ Barbe Butschek | May 15, 2007 | ||
|
|||
Barbe
Butschek, Chief Financial Officer
(Principal
Financial Officer)
|